In an earlier study, variants in CDKN1B and CDKNA2/2B were found to be associated with ovarian cancer risk in a combined analysis of 3601 cases and 5705 controls (Gayther et al, 2007). The gene discussed is CDKN1B; the disease is ovarian cancer.